MDGL - MADRIGAL PHARMACEUTICALS, INC.
IEX Last Trade
313.71
1.580 0.504%
Share volume: 4,322
Last Updated: Fri 27 Dec 2024 02:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.33%
PREVIOUS CLOSE
CHG
CHG%
$312.13
1.58
0.51%
Summary score
21%
Profitability
25%
Dept financing
2%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.14%
Return on assets
-9.5%
Return on sales
0%
Return on invested capital
146.09%
Total debt ratio
6.51%
Debt ratio change over timeo
-0.95%
Current Ratio
30.19%
Quick Ratio
0%
Cash Position Ratio
7.71%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.61%
Return on assets
-8.35%
Return on sales
0%
Return on invested capital
126.46%
Total debt ratio
6.99%
Debt ratio change over timeo
-0.95%
Current Ratio
18.5%
Quick Ratio
0%
Cash Position Ratio
2.88%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-14.3%
Return on assets
-12.96%
Return on sales
0%
Return on invested capital
112.72%
Total debt ratio
11.71%
Debt ratio change over time
-0.9%
Current Ratio
8.54%
Quick Ratio
0%
Cash Position Ratio
1.01%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-105.62%
Return on assets
-105.4%
Return on sales
0%
Return on invested capital
-4.86%
Total debt ratio
-95.48%
Debt ratio change over time
-0.95%
Current Ratio
24.36%
Quick Ratio
0%
Cash Position Ratio
6.02%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MDGL | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -10.14% | -3.05% | 11.55% | 6.27% |
| Return on assets | -9.5% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 146.09% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 60% |
| Total debt ratio | 6.51% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.95% | 6.09% | 6.03% | 1.53% |
| Dept financing | 2% | 50% | 43% | 14% |
| Current Ratio | 18.5% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.88% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 14% | 30% | 30% |
| Short-term ratios | MDGL | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.61% | -25.62% | 17.94% | 7.14% |
| Return on assets | -8.35% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 126.46% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 40% | 71% | 61% |
| Total debt ratio | 6.99% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.95% | -23.44% | 9.66% | 0.6% |
| Dept financing | 2% | 25% | 45% | 8% |
| Current Ratio | 18.5% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.88% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 33% | 24% | 43% |